|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/22/2024 |
$0.80 |
$0.81 |
$0.77 |
$0.77 |
2.57M | 03/25/2024 |
$0.78 |
$0.82 |
$0.77 |
$0.79 |
2.72M | 03/26/2024 |
$0.80 |
$0.82 |
$0.75 |
$0.75 |
2.72M | 03/27/2024 |
$0.76 |
$0.80 |
$0.75 |
$0.78 |
3.35M | 03/28/2024 |
$0.79 |
$0.80 |
$0.76 |
$0.77 |
3.02M |
|
Seres Therapeutics is a microbiome therapeutics platform company developing live biotherapeutic drugs. SER-109, Co.'s lead clinical candidate is an oral, purified bacterial spore-based microbiome therapeutic candidate consisting of a consortium of purified Firmicutes spores. Using Co.'s microbiome therapeutics platform, Co. is also developing SER-287 and SER-301 to treat ulcerative colitis. Co. evaluates microbiome pharmacokinetic and pharmacodynamic data from across its clinical and pre-clinical portfolios using its reverse translation microbiome therapeutics capabilities to conduct research on various indications, including inflammatory and immune diseases, cancer, and metabolic diseases. | |
|
Seres Therapeutics (MCRB) has the following price history information. Looking back at MCRB historical stock prices for the last five trading days, on March 22, 2024, MCRB opened at $0.80, traded as high as $0.81 and as low as $0.77, and closed at $0.77. Trading volume was a total of 2.57M shares. On March 25, 2024, MCRB opened at $0.78, traded as high as $0.82 and as low as $0.77, and closed at $0.79. Trading volume was a total of 2.72M shares. On March 26, 2024, MCRB opened at $0.80, traded as high as $0.82 and as low as $0.75, and closed at $0.75. Trading volume was a total of 2.72M shares. On March 27, 2024, MCRB opened at $0.76, traded as high as $0.80 and as low as $0.75, and closed at $0.78. Trading volume was a total of 3.35M shares. On March 28, 2024, MCRB opened at $0.79, traded as high as $0.80 and as low as $0.76, and closed at $0.77. Trading volume was a total of 3.02M shares.
MCRB Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Seres Therapeutics shares, starting with a $10,000 purchase of MCRB, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/29/2015 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$38.00 |
|
End price/share: |
$0.77 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-97.96% |
|
Average Annual Total Return: |
-35.91% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$203.59 |
|
Years: |
8.75 |
|
|
|
Date |
Close |
03/22/2024 | $0.77 | 03/25/2024 | $0.79 | 03/26/2024 | $0.75 | 03/27/2024 | $0.78 | 03/28/2024 | $0.77 |
|
|